; and (B) to update the donor history questionnaire consistent with the updates under subparagraph (A); and (3) not later than 18 months after the date of enactment of this Act— (A) complete the process initiated pursuant to paragraph (2); and (B) publish the updated guidance and donor history questionnaire. (b) Special rule Throughout the period during which the Secretary is revising guidance pursuant to subsection (a)(1), the recommendations described in subparagraphs (A) and (B) of subsections (a)(1) are deemed to be eliminated with respect to any individual who— (1) is a human subject in research; (2) is being routinely tested for human immunodeficiency virus, hepatitis A, and hepatitis B as part of such research; and (3) is not found, pursuant to such testing, to be positive for human immunodeficiency virus, hepatitis A, or hepatitis B. (c) Progress report The Secretary shall— (1) not later than each of 6 and 12 months after the date of enactment of this Act, submit a report to the appropriate congressional committees on the progress made pursuant to the process under subsection (a)(2); and (2) not later than 18 months after the date of enactment of this Act, submit a final report to the appropriate congressional committees on the updated guidance and donor history questionnaire.